Showing 221 - 240 results of 112,045 for search '(( 50 ((ppm decrease) OR (a decrease)) ) OR ( 5 ((ppm decrease) OR (a decrease)) ))', query time: 1.25s Refine Results
  1. 221

    Fig 6 - by B. Ulfhake (6293984)

    Published 2022
    Subjects:
  2. 222

    Fig 12 - by B. Ulfhake (6293984)

    Published 2022
    Subjects:
  3. 223

    Fig 18 - by B. Ulfhake (6293984)

    Published 2022
    Subjects:
  4. 224

    Fig 11 - by B. Ulfhake (6293984)

    Published 2022
    Subjects:
  5. 225
  6. 226
  7. 227

    Fig 1 - by B. Ulfhake (6293984)

    Published 2022
    Subjects:
  8. 228
  9. 229

    Fig 2 - by B. Ulfhake (6293984)

    Published 2022
    Subjects:
  10. 230

    Fig 14 - by B. Ulfhake (6293984)

    Published 2022
    Subjects:
  11. 231
  12. 232
  13. 233

    Erratum: Decrease in Incidence of Bronchopulmonary Dysplasia with Erythropoietin Administration in Preterm Infants: A Retrospective Study by Rayjada N. (4272919)

    Published 2017
    “…<b><i>Objective:</i></b> To determine whether EPO treatment for AOP was associated with a reduced incidence of BPD in premature infants. …”
  14. 234
  15. 235
  16. 236

    Simulated effects of increased pCREB combined with decreased pCaMKIIα on bistability. by Yili Zhang (540283)

    Published 2022
    “…<p>(A1) Modification of model. Increased basal phosphorylation of CREB <i>k</i><sub><i>basalp_creb</i></sub>, concurrent with decreased basal phosphorylation of CaMKIIα <i>k</i><sub><i>basalp_CaMKII</i></sub>, in the absence of the effects of MeCP2/HDAC2/Sin3a (red) ([<i>E</i><sub><i>comp</i></sub>] = 0; [<i>E</i><sub><i>MeCP2</i></sub>] = 0). …”
  17. 237
  18. 238
  19. 239
  20. 240

    CDDO-Me radioprotection decreases with progressive oncogenic manipulations in HBECs and in a matched NSCLC line. by Mariam El-Ashmawy (678638)

    Published 2014
    “…Immortalized HBECs with (A) lenti-<i>KRas</i><sup>V12</sup>, (B) lenti-<i>KRas</i><sup>V12</sup> and sh<i>p53</i> knockdown, and (C) lenti-<i>KRas</i><sup>V12</sup>, sh<i>p53</i>, and <i>myc</i> overexpression. …”